After careful consideration and strategic discussions, we have decided to pause our investment and activities in the clinical trials sector.

This decision aligns with our current focus on strengthening and refining our core services, including shared care programs, continuing professional education for GPs and healthcare professionals, and workforce planning.

We value the interest and support from our stakeholders and believe that this pause will allow us to better position ourselves for future opportunities. We remain committed to our mission and look forward to potential collaborations down the line.